ATE81775T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE81775T1
ATE81775T1 AT88907737T AT88907737T ATE81775T1 AT E81775 T1 ATE81775 T1 AT E81775T1 AT 88907737 T AT88907737 T AT 88907737T AT 88907737 T AT88907737 T AT 88907737T AT E81775 T1 ATE81775 T1 AT E81775T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
idazoxan
carbidopa
alpha
mixture
Prior art date
Application number
AT88907737T
Other languages
English (en)
Inventor
Saad Al-Damluji
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE81775T1 publication Critical patent/ATE81775T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
AT88907737T 1987-09-02 1988-09-01 Pharmazeutische zusammensetzungen. ATE81775T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878720600A GB8720600D0 (en) 1987-09-02 1987-09-02 Pharmaceutical compositions
EP88907737A EP0345304B1 (de) 1987-09-02 1988-09-01 Pharmazeutische zusammensetzungen
PCT/GB1988/000717 WO1989001774A1 (en) 1987-09-02 1988-09-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE81775T1 true ATE81775T1 (de) 1992-11-15

Family

ID=10623138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88907737T ATE81775T1 (de) 1987-09-02 1988-09-01 Pharmazeutische zusammensetzungen.

Country Status (8)

Country Link
US (1) US5015654A (de)
EP (1) EP0345304B1 (de)
JP (1) JPH02500596A (de)
AT (1) ATE81775T1 (de)
DE (1) DE3875611T2 (de)
DK (1) DK211489D0 (de)
GB (2) GB8720600D0 (de)
WO (1) WO1989001774A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109007A (en) * 1989-01-06 1992-04-28 The United States Of America As Represented By The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
US5663167A (en) * 1992-12-09 1997-09-02 The United States Of America As Represented By The Department Of Health And Human Services Antipsychotic composition and method of treatment
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
FR2759291A1 (fr) * 1997-02-13 1998-08-14 Pf Medicament Produit contenant de l'idazoxan et de la 1-dopa comme preparation pharmaceutique combinee utilise pour la maladie de parkinson
WO2005025561A1 (en) * 2003-09-04 2005-03-24 Synergia Pharma, Inc. Compositions and methods for orthostatic intolerance
ES2383768T3 (es) * 2006-06-28 2012-06-26 Chelsea Therapeutics Inc. Composiciones farmacéuticas que comprenden droxidopa
JP2010520885A (ja) * 2007-03-09 2010-06-17 チェルシー・セラピューティクス，インコーポレイテッド 線維筋痛症の治療のためのドロキシドパ及びその医薬組成物
EP2142185B1 (de) * 2007-03-12 2012-08-15 Chelsea Therapeutics, Inc. Droxidopa und pharmazeutische zusammensetzung davon zur behandlung von neural vermittelter hypertonie
US8383681B2 (en) * 2007-05-07 2013-02-26 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4673689A (en) * 1985-09-25 1987-06-16 Massachusetts Institute Of Technology Method and composition for enhancing the effect of indirect-acting sympathomimetic amines

Also Published As

Publication number Publication date
DK211489A (da) 1989-05-01
DE3875611T2 (de) 1993-03-11
WO1989001774A1 (en) 1989-03-09
EP0345304B1 (de) 1992-10-28
GB8720600D0 (en) 1987-10-07
GB2209281B (en) 1991-08-21
DK211489D0 (da) 1989-05-01
US5015654A (en) 1991-05-14
DE3875611D1 (de) 1992-12-03
GB8820654D0 (en) 1988-10-05
EP0345304A1 (de) 1989-12-13
JPH02500596A (ja) 1990-03-01
GB2209281A (en) 1989-05-10

Similar Documents

Publication Publication Date Title
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
ITRM920155A1 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil1h-indol-5-metansolfonammide, relativo procedimento di preparazione e impiego della stessa nel trattamento di mammiferi
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
MY115662A (en) Novel compounds with analgesic effect
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
SE8804629D0 (sv) New therapeutically active compounds
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DK0460062T3 (da) Huperzin A-analoger
DK581889A (da) Antiatherosclerotiske diarylforbindelser
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
SE8204288D0 (sv) Apap-anticidum-komposition
SE9504662D0 (sv) New compounds
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
IT1271398B (it) Composizioni farmaceutiche contenenti derivati polipeptidici del ferro per la terapia marziale
SE8704049D0 (sv) Novel pharmacological compounds
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it